Thomas Perone
Compliance Officer bei OVID THERAPEUTICS INC.
Vermögen: 39 603 $ am 31.05.2024
Aktive Positionen von Thomas Perone
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OVID THERAPEUTICS INC. | Compliance Officer | - | - |
| General Counsel | 21.03.2019 | - | |
| Unternehmenssekretär | 21.03.2019 | - |
Karriereverlauf von Thomas Perone
Ehemalige bekannte Positionen von Thomas Perone
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CELGENE | General Counsel | 01.04.2006 | - |
| Unternehmenssekretär | 01.06.2014 | 01.05.2018 | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | General Counsel | 01.12.2001 | 01.04.2006 |
| Proskauer Rose LLC | Corporate Officer/Principal | - | - |
Ausbildung von Thomas Perone
| Fairleigh Dickinson University | Masters Business Admin |
| Seton Hall University School of Law | Graduate Degree |
| Rutgers State University of New Jersey | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Frankreich | 2 |
Operativ
| General Counsel | 3 |
| Corporate Secretary | 2 |
| Compliance Officer | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OVID THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
| Proskauer Rose LLC |
- Börse
- Insiders
- Thomas Perone
- Erfahrung